Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group-Reference-Cited by-同舟云学术

Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group

Published:2011-04-04 Issue:5 Volume:52 Page:833-841
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Buckstein Rena,Kuruvilla John,Chua Neil,Lee Christina,Macdonald David A.,Al-tourah Abdulwahab J.,Foo Alison H.,Walsh Wendy,Percy ivy S.,Crump Michael,Eisenhauer Elizabeth A.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.555892

Reference45 articles.

1. Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

2. Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma

3. Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Identification and Functional Characterization of Genetic Variations across DLBCL Cell Lines;Cells;2023-02-12

2. B-cell non-Hodgkin lymphoma: importance of angiogenesis and antiangiogenic therapy;Angiogenesis;2020-05-25

3. Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the Ras pathway;European Journal of Pharmacology;2019-01

4. Successful treatment of advanced pancreatic liposarcoma with apatinib: A case report and literature review;Cancer Biology & Therapy;2017-07-05

5. Diffuse large B-cell lymphoma: R-CHOP failure—what to do?;Hematology;2016-12-02